title: Lanreotide autogel-induced tumour shrinkage in thyrotropin-secreting pituitary macroadenomas.
authors.forename: Amalia-Elisa
authors.initials: AE
authors.lastname: Paniagua
authors.forename: Ignacio
authors.initials: I
authors.lastname: Bernabeu
authors.forename: Susanna
authors.initials: S
authors.lastname: Leskela
authors.forename: Mónica
authors.initials: M
authors.lastname: Marazuela
mesh_terms: D000236:Adenoma / Q000188:drug therapy* / Q000378:metabolism; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005782:Gels; D006801:Humans; D008297:Male; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013972:Thyrotropin / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D005782:Gels; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D013972:Thyrotropin